Irish Life Investment Managers’s Emergent Biosolutions EBS Stock Holding History

Irish Life Investment Managers’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$21.7K	Buy	+1,505	New	+$21.8K	﹤0.01%	1854

Other funds holding EBS

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Irish Life Investment Managers's EBS Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Emergent Biosolutions (EBS) in Q2 2013: 1,505 shares worth $21.7K. The stake represents ﹤0.01% of the portfolio and ranks #1854 among its holdings.

113 funds tracked by Wall St. Rank hold EBS as of Q2 2013.

Irish Life Investment Managers held 1,505 shares of Emergent Biosolutions worth $21.7K as of Q2 2013.
Emergent Biosolutions was a new Irish Life Investment Managers position in Q2 2013.
Emergent Biosolutions made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1854 holding.
113 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.